This article has been updated to correct the drug's potential brandname in the EU.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – A genome-wide association study by Novartis researchers has identified genetic variants linked to liver injury in some individuals taking the anti-inflammatory drug lumiracoxib.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.